Live now- digestible, intelligent, portable #MedEd The OJC Episode 40: ASCO GI Special oncologynews.com.au/the-ojc-episod… great work Prof. Eva Segelov Hans Prenen Oncology News Australia Marc Peeters Pamela Kunz, MD #asco21 #gicancer

This was an excellent introduction to the COVID-19 and Cancer Consortium (CCC19) Registry community, and one that I am excited to continue working on in the vein of #immunocompromised host and #TxID , especially as #CCC19 continues to grow to 11k+ total registrants since #ASCO21

NEW PODCAST: Chewing the ASCO 2021 Fat with Bishal Gyawali. Thanks to Bishal Gyawali, Prof. Eva Segelov and Hans Prenen for another fascinating ASCO analysis podcast! oncologynews.com.au/the-ojc-episod… #ctDNA #clinicaltrials #ASCO2021 #OJC #MedEd Craig Underhill

The benefits of #5G are making a difference for companies everywhere.

Visit #5G HQ and learn how it can help give your organization a boost:
t-mo.co/3Lg37An

Thanks Seamus O’Reilly & ISMO for the invitation to discuss #ASCO21 #gynonc highlights

So many tour-de-force presentations from Jarushka Naidoo Deirdre O’Mahony Dr Brian Healey Bird Seamus O’Reilly Mark Doherty & others

#sorrynotsorry for exceeding my alloted time - I ❤️ talking GYN onc!

#breastcancer #ASCO21 #YaleASCO21 Yale Cancer Center

What is next after #OlympiA and ECOG-ACRIN Cancer Research Group EA1131 for #TNBC ? A panel discussion with @SMougalian #LajosPusztai and #NeilFischbach #bcsm

I received my certificate #ASCO21 Merit Award ! many thanks to GustaveRoussy & #Zitvogel for the opportunity to present : 'Intestinal Akkermansia muciniphila predicts overall survival in advanced non-small cell lung cancer #NSCLC patients treated with anti-PD-1 antibodies '

Congratulations Kyle T Enriquez (M2) on his COVID-19 presentation!

Cancer research funding shouldn't be a popularity contest. We need to ensure cancers that have the highest mortality rates and are very common get the funding they need. #ASCO21 #CleClinicCancer #cancer

How funding trails follow popularity over need: great work on funding disparities by Suneel Kamath MD #ASCO21 👏

Disparities in Government and Nonprofit Funding Affect Cancers with High Mortality Rates – Consult QD consultqd.clevelandclinic.org/disparities-in…

Engage a palliative care team soon after a diagnosis like pancreatic cancer. It helps people w cancer, and their families, live better.

Here is a trial presented at #asco21 looking at early palliative care. #pancchat
👇 👇

twitter.com/ShaalanBeg/sta…

Que linda manera de finalizar los encuentros federales 🇦🇷Tumores #GU , con las novedades de #ASCO21 !
FLoscoMD Andres Rodriguez Dr. Tomás Soulé Gustavo Villoldo Mario Damiano Juan Pablo Sade Lisandro Paganini Cinthia Joaquin Chemi
#UroOncoIAF
¡GRACIAS!

Simul Parikh Abhinav "Abhi" Reddy Nat Lester-Coll, MD Here’s the OPRA update from ASCO21. ~ 40% cCR and another ~ 40% nCR. ~ 80% and ~50% 3-yr organ preservation, respectively. Exciting to see data like this! ⬆️patient QoL Manju George MVSc PhD Rectal Cancer Survivor

ascopubs.org/doi/abs/10.120…

Join Heather McArthur, MD, MPH Ezra Cohen Eric D Whitman, MD ILSON David for a post #ASCO21 review. I'll be there!
cvent.com/d/7mq70f

ASCO @CSCancerCare MD Anderson Cancer Center Atlantic Health Herbert Irving Comprehensive Cancer Center UC San Diego

No one has done more to advance the cause of women in GI cancer- thank you Pamela Kunz, MD. And for your exceptional #ASCO21 GI analysis, with our good friend & coffee addict Marc Peeters. Go Belgian listeners! Thanks Hans Prenen Craig Underhill #OJC poddies

Great session on Mental Health and well being in cancer patients at #ASCO21 by, among others, two examples of clinical excellence Daniel E Spratt and Lori Pierce . Inspiring thoughts about such an important, but not oft enough discussed, topic UMich Rad Onc

And finally, I am grateful for social media for discussions but...

Call me old-school, I don’t think social media metrics are the way to measure who/what #ASCO21 messages will have a greater benefit for patients. IMO that path could be misleading, be cautious please
(3/3)

AR technology can bring human-focused design, immediate access to knowledge and thousands of dollars in training savings.

One for all the Bishal Gyawali fan club- I’m so there! COSA Medical Oncology Group of Australia Craig Underhill #OJC #ASCO21

Adjuvant Rx in urothelial cancer and 'consensus views'

POUT: RFS 0.51- signif; OS 0.70 - not signif ASCO21
-> 'let's do this!!' 😀

EORTC 30994: RFS 0.54 - signif; OS 0.78 - not signif
-> 'unresolved'

CM274 PD-L1+ve: RFS 0.54 - signif, OS immature
-> 'have to await OS'

POUT:🧐

My favorites: bubble candles, a miracle washing machine cleaner, genius silverware storage, and Amazon's most perfect leggings with 70K+ reviews.

Grateful for this amazing opportunity! Thank you to Conquer Cancer, the ASCO Foundation and my great mentors that made this possible 🌟🌟 #ASCO21 #LatinasinMedicine

Embedded imaging & biospecimen analysis will be very insightful: PBMC, ctDNA, CTC every 12 weeks + biopsy at 3 time points. Striking difference in PSA50RR (73% vs 28%) compared to Thomas Hope #ASCO21 study.

Honor to discuss points Dr. Bishoy M. Faltas Shilpa Gupta #ASCO21 ASCO AMBASSADOR Andrea Apolo, M.D. PROOF302 Sumanta K. Pal, MD, FASCO Sia Daneshmand, M.D. JavelinBladder100 Tom Powles S1806 Parminder singh KN992 Arjun Balar MD EA8185 MJ & other studies! Bladder Cancer Advocacy Network Ali Khaki Neeraj Agarwal, MD, FASCO OncoAlert

Let's Close the Gap: #ASCO21 Research Addresses Disparities in Lung Cancer Screening by Coral Olazagasti, MD & Nagashree Seetharamu #lcsm #healthdisparities @cohttps://dailynews.ascopubs.org/do/10.1200/ADN.21.200659/full/#.YO4-WGtStao.twitter

Hear how novel therapeutics have expanded treatment options for #CLL from an expert panel, featuring Matthew Davids, MD, MMSc, Nitin Jain, and Deborah Stephens. Watch this video today! #ASCO21 PeerView bit.ly/2RQoz7I

Are there any final questions? #PancChat

Thank you to all our team and incredible mentors of the Mayo-UAB Histiocytosis Working Group 🎉 🙌🏼

Honored to have presented amongst so many incredible colleagues and to have our work highlighted as a Top 3 Abstract in the #ASCO21 Med Student & Resident Forum!